[1]
“Nilotinib effect on hepatic and renal functions in a sample of Iraqi patients with chronic myeloid leukemia”, Iraqi j. cancer med. genet., vol. 10, no. 1, Jun. 2017, doi: 10.29409/ijcmg.v10i1.197.